Not Medicare Enrolled

Dr. Steven Machlin, M.D.

Psychiatry · Fort Myers, FL
Low-engagement
6820 PORTO FINO CIR STE 1, Fort Myers, FL 33912
2392251364
In practice since 2006 (19 years)
NPI: 1063504371 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Machlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Machlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Machlin

Dr. Steven Machlin is a psychiatry specialist in Fort Myers, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Machlin received a total of $12,243 from 39 pharmaceutical and/or device companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Machlin is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $12,243 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,243
Total received (2018-2024)
Avg $1,749/year across 7 years
Top 7% in FL for psychiatry
39
Companies
616
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,243 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,703
2023
$2,240
2022
$1,973
2021
$1,780
2020
$1,246
2019
$1,579
2018
$1,721

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$1,253
Teva Pharmaceuticals USA, Inc.
$1,248
Sunovion Pharmaceuticals Inc.
$1,144
Otsuka America Pharmaceutical, Inc.
$1,079
Neurocrine Biosciences, Inc.
$1,004
Lundbeck LLC
$774
ITI, Inc.
$608
Allergan Inc.
$522
ABBVIE INC.
$375
Avanir Pharmaceuticals, Inc.
$366
Corium, LLC
$331
AbbVie Inc.
$290
Bausch Health US, LLC
$277
Axsome Therapeutics, Inc.
$245
Tris Pharma Inc
$243
Vanda Pharmaceuticals Inc.
$242
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$226
JAZZ PHARMACEUTICALS INC.
$214
Allergan, Inc.
$205
Ironshore Pharmaceuticals Inc.
$189
Almatica Pharma LLC
$175
Adlon Therapeutics L.P.
$165
Janssen Pharmaceuticals, Inc
$158
Shire North American Group Inc
$142
Alkermes, Inc.
$131
Noven Therapeutics, LLC
$126
Jazz Pharmaceuticals Inc.
$89
ACADIA Pharmaceuticals Inc
$56
IRONSHORE PHARMACEUTICALS INC.
$50
Neos Therapeutics, LP
$47
Validus Pharmaceuticals LLC
$46
Merck Sharp & Dohme Corporation
$46
IDORSIA PHARMACEUTICALS US INC
$42
LivaNova USA, Inc.
$41
Harmony Biosciences LLC
$25
Novo Nordisk Inc
$23
HARMONY BIOSCIENCES LLC
$17
Supernus Pharmaceuticals, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$15
Top 3 companies account for 29.8% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · CITALOPRAM · Dyanavel XR · Equetro · Fanapt · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · NUEDEXTA · NUPLAZID · Nuedexta · QELBREE · QUVIVIQ · Quillichew ER · REXULTI · SECUADO · SERTRALINE HCL · SPRAVATO · SUNOSI · Sunosi · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VNS - Symmetry · VNS Therapy · VRAYLAR · VYVANSE · Vyvanse · WELLBUTRIN · WELLBUTRIN XL · Wakix · Wegovy · Xelstrym · Zenzedi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in FL.

Looking for a psychiatry specialist in Fort Myers?
Compare psychiatrists in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
98
Per 100K population
12.4
County median income
$73,099
Nearest hospital
GULF COAST MEDICAL CENTER LEE HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Machlin is a psychiatry specialist, with low-engagement industry engagement in the top 7% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Machlin receive payments from pharmaceutical companies?
Yes. Dr. Machlin received a total of $12,243 from 39 companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Machlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →